Surgical Site Infection (SSI) Market by Product (Antibiotic Prophylaxis Products, Antiseptics & Disinfectants, Wound Care Dressings, Surgical Drapes, Surgical Staff Clothing, Patient-Warming Products, Wound Care Supplementary Products, Clippers, Wound Irrigation Products), by Phase (Intraoperative Phase, Preoperative Phase, Postoperative Phase), by End User (Hospitals, Ambulatory Surgical Centers [ASCs], Clinics), by Geography (U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, China, India, Australia, South Korea, Brazil, Mexico, Saudi Arabia, South Africa) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2013–2023

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Product

1.3.2 Market Segmentation by Phase

1.3.3 Market Segmentation by End User

1.3.4 Market Segmentation by Geography

1.3.5 Analysis Period

1.3.6 Market Data Reporting Unit

1.3.6.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Product

4.1.1.1 Antibiotic prophylaxis products

4.1.1.2 Antiseptics and disinfectants

4.1.1.3 Clippers

4.1.1.4 Patient-warming products

4.1.1.5 Wound care dressings

4.1.1.6 Wound care supplementary products

4.1.1.7 Surgical drapes

4.1.1.8 Surgical staff clothing

4.1.1.9 Wound irrigation products

4.1.1.10 Others

4.1.2 By Phase

4.1.2.1 Preoperative phase

4.1.2.2 Intraoperative phase

4.1.2.3 Postoperative phase

4.1.3 By End User

4.1.3.1 Hospitals

4.1.3.2 Clinics

4.1.3.3 Ambulatory surgery centers (ASCs)

4.1.3.4 Others

4.2 Market Dynamics

4.2.1 Drivers

4.2.1.1 Rising incidence of SSIs

4.2.1.2 Increasing number of surgical procedures

4.2.1.3 Development of technologically advanced products

4.2.1.4 Growing geriatric population

4.2.1.5 Impact analysis of drivers on market forecast

4.2.2 Restraints

4.2.2.1 Low preventive measures for nosocomial infections in developing nations

4.2.2.2 Lack of awareness about SSIs

4.2.2.3 Impact analysis of restraints on market forecast

4.2.3 Opportunities

4.2.3.1 Increasing initiatives by various organizations

4.2.3.2 Collaborations to prevent SSIs

4.3 Porter’s Five Forces Analysis

4.3.1 Bargaining Power of Buyers

4.3.2 Bargaining Power of Suppliers

4.3.3 Intensity of Rivalry

4.3.4 Threat of New Entrants

4.3.5 Threat of Substitutes

Chapter 5. SSI Incidence and Forecast

5.1 U.S. SSI Incidence and Forecast by Surgery Type

5.2 Canada SSI Incidence and Forecast by Surgery Type

5.3 Germany SSI Incidence and Forecast by Surgery Type

5.4 U.K. SSI Incidence and Forecast by Surgery Type

5.5 France SSI Incidence and Forecast by Surgery Type

5.6 Italy SSI Incidence and Forecast by Surgery Type

5.7 Spain SSI Incidence and Forecast by Surgery Type

5.8 Japan SSI Incidence and Forecast by Surgery Type

5.9 China SSI Incidence and Forecast by Surgery Type

5.10 India SSI Incidence and Forecast by Surgery Type

5.11 Australia SSI Incidence and Forecast by Surgery Type

5.12 South Korea SSI Incidence and Forecast by Surgery Type

5.13 Brazil SSI Incidence and Forecast by Surgery Type

5.14 Mexico SSI Incidence and Forecast by Surgery Type

5.15 Saudi Arabia SSI Incidence and Forecast by Surgery Type

5.16 South Africa SSI Incidence and Forecast by Surgery Type

Chapter 6. Global Market Size and Forecast

6.1 By Product

6.2 By Phase

6.2.1 Global Intraoperative SSI Market, by Product

6.2.2 Global Preoperative SSI Market, by Product

6.2.3 Global Postoperative SSI Market, by Product

6.3 By End User

6.3.1 Number of End Users Utilizing SSI Preventive Products

6.4 By Region

Chapter 7. North America Market Size and Forecast

7.1 By Product

7.2 By Phase

7.2.1 North America Intraoperative SSI Market, by Product

7.2.2 North America Preoperative SSI Market, by Product

7.2.3 North America Postoperative SSI Market, by Product

7.3 By End User

7.3.1 Number of End Users Utilizing SSI Preventive Products

7.4 By Country

Chapter 8. Europe Market Size and Forecast

8.1 By Product

8.2 By Phase

8.2.1 Europe Intraoperative SSI Market, by Product

8.2.2 Europe Preoperative SSI Market, by Product

8.2.3 Europe Postoperative SSI Market, by Product

8.3 By End User

8.3.1 Number of End Users Utilizing SSI Preventive Products

8.4 By Country

Chapter 9. APAC Market Size and Forecast

9.1 By Product

9.2 By Phase

9.2.1 APAC Intraoperative SSI Market, by Product

9.2.2 APAC Preoperative SSI Market, by Product

9.2.3 APAC Postoperative SSI Market, by Product

9.3 By End User

9.3.1 Number of End Users Utilizing SSI Preventive Products

9.4 By Country

Chapter 10. RoW Market Size and Forecast

10.1 By Product

10.2 By Phase

10.2.1 ROW Intraoperative SSI Market, by Product

10.2.2 ROW Preoperative SSI Market, by Product

10.2.3 ROW Postoperative SSI Market, by Product

10.3 By End User

10.3.1 Number of End Users Utilizing SSI Preventive Products

10.4 By Country

Chapter 11. Competitive Landscape

11.1 Market Share Analysis of Key Players

11.2 Product Benchmarking of Key Players

11.3 Global Strategic Developments of Key Players

11.3.1 Mergers and Acquisitions

11.3.2 Partnerships

11.3.3 Other Developments

Chapter 12. Company Profiles

12.1 Global Key Players

12.1.1 3M Company

12.1.1.1 Business overview

12.1.1.2 Product and service offerings

12.1.1.3 Key financial summary

12.1.1.4 Strategic growth plans

12.1.2 B. Braun Melsungen AG

12.1.2.1 Business overview

12.1.2.2 Product and service offerings

12.1.2.3 Key financial summary

12.1.2.4 Strategic growth plans

12.1.3 Becton, Dickinson and Company

12.1.3.1 Business overview

12.1.3.2 Product and service offerings

12.1.3.3 Key financial summary

12.1.3.4 Strategic growth plans

12.1.4 STERIS plc

12.1.4.1 Business overview

12.1.4.2 Product and service offerings

12.1.4.3 Key financial summary

12.1.4.4 Strategic growth plans

12.1.5 Stryker Corporation

12.1.5.1 Business overview

12.1.5.2 Product and service offerings

12.1.5.3 Key financial summary

12.1.5.4 Strategic growth plans

12.1.6 Medtronic plc

12.1.6.1 Business overview

12.1.6.2 Product and service offerings

12.1.6.3 Key financial summary

12.1.6.4 Strategic growth plans

12.1.7 Prescient Surgical Inc.

12.1.7.1 Business overview

12.1.7.2 Product and service offerings

12.1.8 Covalon Technologies Ltd.

12.1.8.1 Business overview

12.1.8.2 Product and service offerings

12.1.8.3 Key financial summary

12.1.9 Surgical Site Infection Prevention LLC

12.1.9.1 Business overview

12.1.9.2 Product and service offerings

12.1.10 Mölnlycke Health Care AB

12.1.10.1 Business overview

12.1.10.2 Product and service offerings

12.1.10.3 Key financial summary

12.1.11 HARTMANN GROUP

12.1.11.1 Business overview

12.1.11.2 Product and service offerings

12.1.11.3 Key financial summary

12.2 Regional Players

12.2.1 Nex Medical Antiseptics Srl

12.2.2 Medica Europe BV

12.2.3 Exoxemis Inc.

12.2.4 MEDi-Lin

12.2.5 Winner Medical Co. Ltd.

12.2.6 Shalex Overseas Pvt. Ltd.

Chapter 13. Appendix

13.1 Abbreviations

13.2 Sources and References

13.3 Related Report

 

List of Tables

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 U.S. SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013–2020)

TABLE 3 CANADA SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013–2020)

TABLE 4 GERMANY SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013–2020)

TABLE 5 U.K. SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013–2020)

TABLE 6 FRANCE SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013–2020)

TABLE 7 ITALY SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013–2020)

TABLE 8 SPAIN. SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013–2020)

TABLE 9 JAPAN SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013–2020)

TABLE 10 CHINA SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013–2020)

TABLE 11 INDIA SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013–2020)

TABLE 12 AUSTRALIA SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013–2020)

TABLE 13 SOUTH KOREA SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013–2020)

TABLE 14 BRAZIL SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013–2020)

TABLE 15 MEXICO SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013–2020)

TABLE 16 SAUDI ARABIA SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013–2020)

TABLE 17 SOUTH AFRICA SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013–2020)

TABLE 18 GLOBAL SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 19 GLOBAL SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 20 GLOBAL SSI MARKET, BY PHASE, $M (2019–2024)

TABLE 21 GLOBAL SSI MARKET, BY PHASE, $M (2025–2030)

TABLE 22 GLOBAL INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 23 GLOBAL INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 24 GLOBAL PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 25 GLOBAL PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 26 GLOBAL POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 27 GLOBAL POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 28 GLOBAL SSI MARKET, BY END USER, $M (2019–2024)

TABLE 29 GLOBAL SSI MARKET, BY END USER, $M (2025–2030)

TABLE 30 GLOBAL SSI MARKET, BY REGION, $M (2019–2024)

TABLE 31 GLOBAL SSI MARKET, BY REGION, $M (2025–2030)

TABLE 32 NORTH AMERICA SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 33 NORTH AMERICA SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 34 NORTH AMERICA SSI MARKET, BY PHASE, $M (2019–2024)

TABLE 35 NORTH AMERICA SSI MARKET, BY PHASE, $M (2025–2030)

TABLE 36 NORTH AMERICA INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 37 NORTH AMERICA INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 38 NORTH AMERICA PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 39 NORTH AMERICA PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 40 NORTH AMERICA POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 41 NORTH AMERICA POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 42 NORTH AMERICA SSI MARKET, BY END USER, $M (2019–2024)

TABLE 43 NORTH AMERICA SSI MARKET, BY END USER, $M (2025–2030)

TABLE 44 NORTH AMERICA SSI MARKET, BY COUNTRY, $M (2019–2024)

TABLE 45 NORTH AMERICA SSI MARKET, BY COUNTRY, $M (2025–2030)

TABLE 46 EUROPE SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 47 EUROPE SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 48 EUROPE SSI MARKET, BY PHASE, $M (2019–2024)

TABLE 49 EUROPE SSI MARKET, BY PHASE, $M (2025–2030)

TABLE 50 EUROPE INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 51 EUROPE INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 52 EUROPE PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 53 EUROPE PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 54 EUROPE POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 55 EUROPE POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 56 EUROPE SSI MARKET, BY END USER, $M (2019–2024)

TABLE 57 EUROPE SSI MARKET, BY END USER, $M (2025–2030)

TABLE 58 EUROPE SSI MARKET, BY COUNTRY, $M (2019–2024)

TABLE 59 EUROPE SSI MARKET, BY COUNTRY, $M (2025–2030)

TABLE 60 APAC SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 61 APAC SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 62 APAC SSI MARKET, BY PHASE, $M (2019–2024)

TABLE 63 APAC SSI MARKET, BY PHASE, $M (2025–2030)

TABLE 64 APAC INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 65 APAC INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 66 APAC PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 67 APAC PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 68 APAC POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 69 APAC POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 70 APAC SSI MARKET, BY END USER, $M (2019–2024)

TABLE 71 APAC SSI MARKET, BY END USER, $M (2025–2030)

TABLE 72 APAC SSI MARKET, BY COUNTRY, $M (2019–2024)

TABLE 73 APAC SSI MARKET, BY COUNTRY, $M (2025–2030)

TABLE 74 ROW SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 75 ROW SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 76 ROW SSI MARKET, BY PHASE, $M (2019–2024)

TABLE 77 ROW SSI MARKET, BY PHASE, $M (2025–2030)

TABLE 78 ROW INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 79 ROW INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 80 ROW PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 81 ROW PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 82 ROW POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2024)

TABLE 83 ROW POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2025–2030)

TABLE 84 ROW SSI MARKET, BY END USER, $M (2019–2024)

TABLE 85 ROW SSI MARKET, BY END USER, $M (2025–2030)

TABLE 86 ROW SSI MARKET, BY COUNTRY, $M (2019–2024)

TABLE 87 ROW SSI MARKET, BY COUNTRY, $M (2025–2030)

TABLE 88 3M COMPANY – AT A GLANCE

TABLE 89 3M COMPANY – KEY FINANCIAL SUMMARY

TABLE 90 B. BRAUN MELSUNGEN AG – AT A GLANCE

TABLE 91 B. BRAUN MELSUNGEN AG – KEY FINANCIAL SUMMARY

TABLE 92 BECTON, DICKINSON AND COMPANY – AT A GLANCE

TABLE 93 BECTON, DICKINSON AND COMPANY – KEY FINANCIAL SUMMARY

TABLE 94 STERIS PLC – AT A GLANCE

TABLE 95 STERIS PLC – KEY FINANCIAL SUMMARY

TABLE 96 STRYKER CORPORATION – AT A GLANCE

TABLE 97 STRYKER CORPORATION – KEY FINANCIAL SUMMARY

TABLE 98 MEDTRONIC PLC – AT A GLANCE

TABLE 99 MEDTRONIC PLC - KEY FINANCIAL SUMMARY

TABLE 100 PRESCIENT SURGICAL INC. – AT A GLANCE

TABLE 101 COVALON TECHNOLOGIES LTD. – AT A GLANCE

TABLE 102 COVALON TECHNOLOGIES LTD. – KEY FINANCIAL SUMMARY

TABLE 103 SURGICAL SITE INFECTION PREVENTION LLC – AT A GLANCE

TABLE 104 MÖLNLYCKE HEALTH CARE AB – AT A GLANCE

TABLE 105 MÖLNLYCKE HEALTH CARE AB – KEY FINANCIAL SUMMARY

TABLE 106 HARTMANN GROUP – AT A GLANCE

TABLE 107 HARTMANN GROUP – KEY FINANCIAL SUMMARY

TABLE 108 NEX MEDICAL ANTISEPTICS SRL – AT A GLANCE

TABLE 109 MEDICA EUROPE BV – AT A GLANCE

TABLE 110 EXOXEMIS INC. – AT A GLANCE

TABLE 111 MEDI-LIN – AT A GLANCE

TABLE 112 WINNER MEDICAL CO. LTD. – AT A GLANCE

TABLE 113 SHALEX OVERSEAS PVT. LTD. – AT A GLANCE

 

List of Figures

 

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH

FIG 8 GLOBAL SSI MARKET SUMMARY

FIG 9 GERIATRIC POPULATION AS A PERCENTAGE OF TOTAL POPULATION

FIG 10 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

FIG 11 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

FIG 12 PORTER’S FIVE FORCES ANALYSIS

FIG 13 GLOBAL SSI MARKET SPLIT, BY PRODUCT (2023)

FIG 14 GLOBAL SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 15 GLOBAL SSI MARKET SPLIT, BY PHASE (2023)

FIG 16 GLOBAL SSI MARKET, BY PHASE, $M (2019–2030)

FIG 17 GLOBAL INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 18 GLOBAL PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 19 GLOBAL POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 20 GLOBAL SSI MARKET SPLIT, BY END USER (2023)

FIG 21 GLOBAL SSI MARKET, BY END USER, $M (2019–2030)

FIG 22 NUMBER OF END USERS UTILIZING SSI PREVENTIVE PRODUCTS GLOBALLY (2023)

FIG 23 WORLDWIDE MAJOR MARKETS FOR SSI

FIG 24 NORTH MAERICA SSI MARKET SNAPSHOT

FIG 25 NORTH AMERICA SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 26 NORTH AMERICA SSI MARKET, BY PHASE, $M (2019–2030)

FIG 27 NORTH AMERICA INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 28 NORTH AMERICA PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 29 NORTH AMERICA POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 30 NORTH AMERICA SSI MARKET, BY END USER, $M (2019–2030)

FIG 31 NUMBER OF END USERS UTILIZING SSI PREVENTIVE PRODUCTS IN NORTH AMERICA (2023)

FIG 32 NORTH AMERICA SSI MARKET, BY COUNTRY, $M (2019–2030)

FIG 33 EUROPE SSI MARKET SNAPSHOT

FIG 34 EUROPE SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 35 EUROPE SSI MARKET, BY PHASE, $M (2019–2030)

FIG 36 EUROPE INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 37 EUROPE PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 38 EUROPE POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 39 EUROPE SSI MARKET, BY END USER, $M (2019–2030)

FIG 40 NUMBER OF END USERS UTILIZING SSI PREVENTIVE PRODUCTS IN EUROPE (2023)

FIG 41 EUROPE SSI MARKET, BY COUNTRY, $M (2019–2030)

FIG 42 APAC SSI MARKET SNAPSHOT

FIG 43 APAC SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 44 APAC SSI MARKET, BY PHASE, $M (2019–2030)

FIG 45 APAC INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 46 APAC PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 47 APAC POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 48 APAC SSI MARKET, BY END USER, $M (2019–2030)

FIG 49 NUMBER OF END USERS UTILIZING SSI PREVENTIVE PRODUCTS IN APAC (2023)

FIG 50 APAC SSI MARKET, BY COUNTRY, $M (2019–2030)

FIG 51 ROW SSI MARKET SNAPSHOT

FIG 52 ROW SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 53 ROW SSI MARKET, BY PHASE, $M (2019–2030)

FIG 54 ROW INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 55 ROW PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 56 ROW POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2019–2030)

FIG 57 ROW SSI MARKET, BY END USER, $M (2019–2030)

FIG 58 NUMBER OF END USERS UTILIZING SSI PREVENTIVE PRODUCTS IN ROW (2023)

FIG 59 ROW SSI MARKET, BY COUNTRY, $M (2019–2030)

FIG 60 GLOBAL SSI MARKET SHARE OF KEY PLAYERS (2023)

FIG 61 PRODUCT BENCHMARKING OF KEY PLAYERS

FIG 62 3M COMPANY – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 63 B. BRAUN MELSUNGEN AG – REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2023)

FIG 64 BECTON, DICKINSON AND COMPANY – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 65 STERIS PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 66 STRYKER CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 67 MEDTRONIC PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 68 HARTMANN GROUP – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)